INTRODUCTION
The hypercalcaemic protein, parathyroid hormone-related protein (PTHrP) shares N-terminal sequence similarity with parathyroid hormone (PTH) [1] , binds to the same receptor [2] and produces classical PTH-like effects in tissues such as bone and kidney [3] [4] [5] . PTHrP is overexpressed in squamous carcinoma and by several other types of tumour and circulates at elevated concentrations in patients with humoral hypercalcaemia of malignancy [6, 7] .
The human PTHrP gene is complex: nine exons are present, with coding sequences located only in exons V, VI, VIII and IX ( Figure 1 ). Alternative usage of exons VII, VIII and IX generates transcripts encoding three isoforms of PTHrP of 139, 173 and 141 amino acids in length respectively. The relatively simple PTH gene shares similar exon-intron organization, suggesting that the two are derived from the same ancestral gene (for reviews see [8, 9] ). Three functional promoters have been characterized in the human PTHrP gene: P1 and P3 are classical canonical TATA promoters and initiate transcription at exons I and IV respectively [10] [11] [12] [13] , while P2 is high in GC content and initiates transcription 11 nucleotides 5' to the splice acceptor site of exon III [14] . There is potential for alternative splicing at both the 5' and the 3' ends of the primary human PTHrP transcripts. Although these characteristics allow for the production of at least 15 mature mRNA species (Figure 1 ), the relative abundance of these has not been determined. The pattern is likely to be highly tissuespecific and responsive to external factors, such as hormones and the half-life of c-fos mRNA was unaltered, suggesting a relatively specific effect of EGF. Moreover, only those species of PTHrP mRNA containing two of the alternative 3' exons (exons VII and VIII) were stable, those containing exon IX were not. Reversetranscription PCR demonstrated that EGF produced differential increases in the abundance of PTHrP mRNA species initiated by the three PTHrP promoters. The major effect was seen on the abundance of transcripts initiated by P1 and P2, with less marked regulation of P3-initiated transcripts. Thus EGF regulation of PTHrP gene expression in HaCaT cells is multifactorial and the combination of its actions at the 5' and 3' ends of the gene favours the accumulation of subpopulations of PTHrP mRNA containing exons I, VII and VIII.
growth factors, all acting in concert to regulate the frequency of promoter usage and specific splicing events.
Although PTHrP was first identified as a tumour product, its specific distribution in various normal tissues, including skin [15, 16] , placenta [17] , uterus [18, 19] , smooth muscle [20, 21] and lactating mammary gland [22] as well as in many tissues of the human fetus [23] [24] . The production of a PTH-like substance by normal keratinocytes was first observed by Merendino et al. in 1986 [25] , and since then others have shown that primary human keratinocytes and immortalized and transformed keratinocyte cell lines produce PTHrP in culture [26] [27] [28] [29] . However, the function of PTHrP in this tissue is unknown. When HPV16-immortalized human keratinocytes were stably transfected with a vector encoding antisense PTHrP (1-141) RNA, the inactivation of PTHrP allowed the cells to grow more rapidly [30] . Conversely, epidermal growth factor (EGF), a potent stimulator of keratinocyte growth, stimulates the production of PTHrP in normal human and rat keratinocytes [25, 27] and also in the human osteosarcoma-derived cell line, SaOs-2/B10 [31] .
To study the mechanisms involved in EGF-stimulated PTHrP production by keratinocytes, we utilized the immortalized human keratinocyte cell line, HaCaT [32] , which arose spontaneously in long-term culture of adult skin. The immortal character of the cells is probably conferred, at least in part, by the presence of point mutations on both alleles of the p53 gene [33] . In transplantation experiments in vivo HaCaT cells expressed the normal array of keratin types and produced a fully ordered epidermis [32] . We found that HaCaT cells produced PTHrP constitutively, the levels of which could be dramatically stimulated by treatment with nanomolar concentrations of EGF. The HaCaT cell line therefore provided a suitable model in which to study the mechanisms underlying EGF-stimulated PTHrP gene expression.
EXPERIMENTAL Cell cultures
The clonal cell line, HaCaT, originated in a population of cells grown out from a long-term culture of normal human skin [32] . The cells were routinely maintained in Dulbecco's modification of Eagle's medium (DMEM) containing 10 % (v/v) fetal bovine serum (FBS) and subcultured (1:20) every 6-7 days using 0.5 mM EDTA in PBS (15 min at 37°C) followed by a further 15 min in 0.025 % trypsin/0.5 mM EDTA. RNA was prepared from confluent cells in 150-cm2 Petri dishes incubated in DMEM containing 0.1 % BSA for 16-24 h prior to EGF stimulation. For experiments to determine the half-life of PTHrP mRNA, confluent cells were either untreated or stimulated with EGF for 2 h, and then exposed to actinomycin D (0.8 ,uM) or the specific inhibitor of RNA polymerase II, DRB (5,6-dichloro-l-,8-D ribofuranosylbenzimadazole; Sigma-Aldrich Co., St. Louis, MO, U.S.A.) at a concentration of 25,ug/ml and RNA extracted from duplicate cultures at timed intervals thereafter.
Assays of PTHrP
HaCaT cells were subcultured (1:20) into the wells (area 9.6 cm2) of 6-well plates and grown to confluence (8 x [34] . Synthetic PTHrP demonstrates the full biological activity of the intact PTHrP molecule in this assay and was used as standard.
Northern-blot analysis RNA was extracted from HaCaT cells using the method of Chomcyznski and Sacchi [35] and separated on 1 % (w/v) agarose gels containing formaldehyde. RNA was transferred overnight by capillary action [36] 65 'C for 1-2 h. Some filters were reprobed with the cDNA encoding the human transcription factor c-fos [38] . To permit quantification of the mRNA signals, the filters were then re-probed with either 32P-labelled chicken glyceraldehyde phosphate dehydrogenase (GAPDH) cDNA [39] or an oligonucleotide specific for 18 S rRNA [40] [47] . Placental ALP was assayed in cell extracts by standard spectrophotometric procedures as described previously [42] . Cell extracts were assayed for CAT activity according to published procedures [46] 15 .89). We verified that under these conditions, the yield of amplified product from all the primer combinations (see Figure 5a ) was directly proportional to the number of PCR cycles and amount of input RT-RNA (data not shown). The PCR products were resolved in a 20% (w/v) agarose gel and identified by Southern transfer followed by hybridization with a 32P-labelled internal oligonucleotide probe, obrf 15.8. The target sequence for this probe, as well as the positions for binding of the PCR primers, are denoted by the horizontal arrows in Figure  5 (a). All oligonucleotides were synthesized on an Applied Biosystems DNA synthesizer model 381A and have been described previously [43] .
RESULTS
Using an N-terminal PTHrP RIA [7] , we found that confluent cultures of HaCaT cells constitutively produced significant levels of PTHrP, 300 pmol/l, over a 24 h period. These levels were greatly stimulated when EGF was added to the medium ( Figure  2 ). The effect was concentration-dependent with an ED50 of approximately 2 nM EGF. At the maximal concentration of 10 nM, EGF stimulated PTHrP production by approximately 10-fold. Most of the PTHrP secreted into the medium was found to be biologically active in a bioassay based on the ability of PTHrP to stimulate cyclic AMP accumulation in the osteogenic osteosarcoma-derived cell line, UMR 106.01 [34] . (Figure 3a) . A concentration-dependent effect of EGF on PTHrP expression was also observed at the mRNA level; a maximal effect was obtained after treatment with 1 nM EGF (data not shown). In the experiment depicted in Figure 3( This contrasts with previous studies with a variety of PTHrPexpressing cells, including rat keratinocytes, where treatment with cycloheximide strongly stimulated PTHrP mRNA levels [28, 48] as well as augmenting the response produced by transforming growth factor /6 (TGF,8) [44] .
The effect of EGF on PTHrP gene transcription was determined in nuclear run-on experiments. EGF treatment (0.5 h) increased the abundance of radiolabelled nuclear PTHrP transcripts approximately 4-fold relative to unstimulated controls (Figure 4a ). This increased rate of transcription was maintained for 8 h and was accompanied by a 10-fold increase in the abundance of cytoplasmic PTHrP mRNA (Figure 4b) to 10 nM EGF (Figure 5b ). Figure 4 (c) depicts the CAT activity in extracts of HaCaT cells transfected with pSMR492, pSMR38 and pZMR30 [45] . pSMR492 contains the upstream TATA promoter (P1) and 355 bp of 5' flanking sequence, while pZMR30 contains the sequence -530 to -20, thereby excluding the GCrich promoter, P2 [14] . The effect of EGF on the CAT activity of cells transfected with both these constructs was consistently less marked than that produced by cells transfected with pSMR38 ( Figure 5c Figure 7 Stability of PTHrP transcripts encoding each of the three alternative 3' exons in the presence of EGF Total RNA from the same experiment depicted in Figure 6 was subjected to Northern-blot analysis and probed with cDNA probes specific for each of the three alternative 3' exons as described in the Experimental section. agreement with previous reports [28, 44] . However in experiments where EGF was first added to HaCaT cells for 2 h, followed by the addition of actinomycin D, PTHrP mRNA was considerably more stable, and the level was diminished by 500% only after 10-20 h of actinomycin D treatment ( Figure 6 ). This effect appeared to be rather specific since the stability of c-fos mRNA, which is also up-regulated at the transcriptional level by EGF, was unchanged in the presence of EGF ( Figure 6 ). The EGFstimulated increase in the half-life of PTHrP mRNA was obtained in similar experiments where DRB was used as the transcriptional inhibitor (data not shown). To determine whether the ability of EGF to stabilize PTHrP mRNA was the same for transcripts containing each of the alternative 3' exons, Northern-blot analyses using cDNA probes specific for exons VII, VIII and IX were conducted. We found that the probes specific for exons VII and VIII produced strong hybridization signals in the EGFtreated samples and that these mRNA species were very stable. Only a very weak signal corresponding to transcripts containing exon VII was obtained in the control samples and it was not possible to determine the half-life of these species. However, strong signals corresponding to species containing exon VIII were present in control samples and these transcripts appeared to be constitutively stable ( Figure 7 
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Regulation of parathyroid hormone-related protein gene expression under the PCR conditions employed. The RT-PCR products were verified by Southern-blot analysis using a radiolabelled oligonucleotide probe (obrf 15.8) complementary to a sequence in exon VI, but not overlapping with the antisense strand-specific primer (Figures 5a and 8a ). With this approach we identified products corresponding to utilization of all three promoters. The most dramatic effect of EGF was seen on products initiated by P1, where there was consistently about a 16-fold increase in the abundance of transcripts containing exon I (Figure 8 ). This contrasted markedly with the result we obtained in the transient transfection assays where EGF appeared to have little effect on the rate of P1 transcription. There was also about a 3-fold increase in the abundance of transcripts initiated by the GC-rich promoter, P2, and a 2.4-fold effect on transcripts initiated by P3. In summary, while we cannot interpret the RT-PCR data to comment on the relative usage of the three promoters in the PTHrP gene, the extent of EGF regulation was greatest on transcripts initiated by P1, then P2 and finally P3.
DISCUSSION
In the human keratinocyte cell line, HaCaT, elevated levels of PTHrP gene expression in response to EGF involved increases in both the rate of transcription and mRNA stability. [54] ). In the second pathway, cytoplasmic transcription factors are directly phosphorylated by the EGF-R itself. In this 'direct effector' model, the activated factors are then translocated to the nucleus where they form active transcriptional complexes on target genes [55] . For example, the transcription factor p91 is directly phosphorylated by the EGF-R in a ligand-dependent manner and produces activation of the c-fos promoter upon binding to the SIE (c-sisinducible element) [56] . At present we cannot conclude that one or both of these mechanisms mediate the transcriptional effects of EGF reported here. However, our finding that the action of EGF on PTHrP gene expression was not inhibited by cycloheximide in HaCaT cells is compatible with both of the mechanisms described above, since neither requires de novo protein synthesis.
EGF was also found to have a marked effect on PTHrP mRNA stability, again through mechanisms independent of de novo mRNA and protein synthesis. EGF-mediated increases in mRNA stability have been reported previously [57] [58] [59] , most notably in the case of EGF-R mRNA [57] . All transcripts of the PTHrP gene contain AUUUA-rich motifs in their 3' untranslated regions (UTRs) which are thought to confer instability upon mRNA (for review see [60] ), contributing to the notion that PTHrP is a member of the 'immediate early' gene family [28] . Surprisingly, our analysis with exon-specific probes revealed that 3' alternative splicing produced species of human PTHrP mRNA that differed in stability. We found that exon VIII-containing PTHrP transcripts were stable in HaCaT cells treated with actinomycin D, whether EGF was present or not. We could not detect exon VII-containing transcripts in control cells but the markedly elevated levels of exon VII-containing transcripts produced in response to EGF were stable in the presence of actinomycin D. In contrast, exon IX-containing transcripts had a relatively short half-life ( Figure 7 ) and though weakly stimulated by EGF, they continued to decay at about the same rate as those in unstimulated cells. Inspection of the nucleotide sequence in the three alternative 3' UTRs revealed the presence of four AUUUA motifs in both exons VII and IX, with three out of the four being closely clustered in both cases. Meanwhile only two more widely spaced AUUUA motifs are present in exon VIII. It has been proposed that the ability of the AU-rich sequence binding proteins, AU-BPs, to form complexes with AUUUA motifs and target these RNAs for rapid degradation may depend on at least three motifs being in close proximity to one another [61, 62] . This might explain why exon VIII-containing transcripts are apparently intrinsically more stable than those containing exon IX (and possibly exon VII). All these data suggest that the ability of EGF to increase PTHrP mRNA stability may depend on at least two mechanisms, one involving the post-translational (or co-translational) stabilization of PTHrP mRNA and the second arising from altered patterns of 3' alternative splicing. For example, transcripts produced by the EGF-activation of PTHrP promoters may be more likely to retain the 'stable' exon VIII than those produced constitutively.
The phenomenon of differential PTHrP mRNA stability may be unique to human PTHrP. While the expression of the rat PTHrP gene is also up-regulated by EGF [28, 63] , the 3-fold increase in PTHrP mRNA levels is less than the 10-fold increase observed in the present study. Interestingly, the rat gene does not contain 3' exons corresponding to exons VII and VIII in the human [9] , which we have demonstrated here to be stable in the presence of EGF. Thus, the more marked responsiveness of the human PTHrP gene may be due partly to the effect of EGF on threonine kinases, producing activation of transcription factors 165 PTHrP mRNA stability.
We have shown that EGF regulation of human PTHrP gene expression is a complex, multifactorial process involving increases in both gene transcription and the stability of PTHrP mRNA. The interaction of these two mechanisms produces dramatically elevated expression of PTHrP which, at least in HaCaT cells, favours the accumulation of transcripts containing exon I at the 5' terminus and either exon VII or exon VIII at the 3' terminus. This would predict the elevated production of the 139 and 173 amino acid isoforms of PTHrP, relative to the 141 amino acid isoform encoded by exon IX-containing transcripts. The significance of this is largely contingent on whether the three isoforms of PTHrP differ in their biological properties. However, this has not been established so far, and indeed we do not know whether intact, full-length PTHrP molecules are secreted or subjected to intracellular processing. Our results suggest that the evolution of a human PTHrP gene containing three alternative 3' exons may have advanced not only to generate the specific isoforms of the protein, but also to permit up-regulation of PTHrP expression through the production of stable forms of mRNA. It remains to be determined whether the regulatory mechanisms invoked here by EGF also iinderly the overproduction of PTHrP in squamous carcinoma and other tumours in which humoral hypercalcaemia is a frequent complication of malignancy.
